Ophthalmic Comprehensive Reports

2024 Glaucoma Pharmaceuticals Market Report: Global Analysis for 2023 to 2029, May, 2024

The “2024 Glaucoma Pharmaceuticals Market Report” features new regional sales forecasts that take into account appreciation of the dollar against other major currencies and an updated analysis of the prevalence and diagnosis of glaucoma that reflects COVID-19 mortality. The report now includes market share analysis of generics and branded drugs by drug class in the United States and Japan and prescription stratification by first-line and adjunctive use in the United States and Western European countries.

This new report also provides an updated analysis of the glaucoma pharma product pipeline, a summary of ongoing clinical trials, a review of Glaukos’ recently approved iDose TR sustained drug delivery device, and survey data on US ophthalmologists’ plans for sustained drug delivery.

Related Reports

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more